Search research articles
Contact Us
Filters
Showing results (11-20 of 92) with videos related to
Page
of 10
Sort By:
Breast Cancer Research : BCR
|
November 16, 2012
FGFR1 amplification and the progression of non-invasive to invasive breast cancer
Alejandro A Gru, D Craig Allred
Nature Clinical Practice. Endocrinology & Metabolism
|
May 24, 2007
The estrogen paradox
Richard J Santen, D Craig Allred
Breast Cancer Research : BCR
|
November 13, 2004
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
D Craig Allred, Powel Brown, Daniel Medina
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2009
"Dwarf" estrogen receptor in breast cancer and resistance to tamoxifen
Amy M Fowler, Richard J Santen, D Craig Allred
Journal of the National Cancer Institute
|
November 21, 2002
Re: The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
Richard R Love, D Craig Allred, David L DeMets
Nature Cell Biology
|
December 25, 2012
Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion
Bin Xue, Kannan Krishnamurthy, D Craig Allred, et al.
Breast Cancer Research and Treatment
|
April 15, 2005
Biomarker profile and genetic abnormalities in lobular carcinoma in situ
Syed K Mohsin, Peter O'Connell, D Craig Allred, et al.
The Journal of Pathology
|
March 14, 2003
Maspin expression in invasive breast cancer: association with other prognostic factors
Syed K Mohsin, Ming Zhang, Gary M Clark, et al.
Journal of Mammary Gland Biology and Neoplasia
|
June 13, 2012
Intra-mammary ductal transplantation: a tool to study premalignant progression
Daniel Medina, David G Edwards, Frances Kittrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2023
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
Jennet M Harvey, Gary M Clark, C Kent Osborne, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 92) with videos related to
Sort By:
Page
of 10
Breast Cancer Research : BCR
|
November 16, 2012
FGFR1 amplification and the progression of non-invasive to invasive breast cancer
Alejandro A Gru, D Craig Allred
Nature Clinical Practice. Endocrinology & Metabolism
|
May 24, 2007
The estrogen paradox
Richard J Santen, D Craig Allred
Breast Cancer Research : BCR
|
November 13, 2004
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
D Craig Allred, Powel Brown, Daniel Medina
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2009
"Dwarf" estrogen receptor in breast cancer and resistance to tamoxifen
Amy M Fowler, Richard J Santen, D Craig Allred
Journal of the National Cancer Institute
|
November 21, 2002
Re: The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
Richard R Love, D Craig Allred, David L DeMets
Nature Cell Biology
|
December 25, 2012
Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion
Bin Xue, Kannan Krishnamurthy, D Craig Allred, et al.
Breast Cancer Research and Treatment
|
April 15, 2005
Biomarker profile and genetic abnormalities in lobular carcinoma in situ
Syed K Mohsin, Peter O'Connell, D Craig Allred, et al.
The Journal of Pathology
|
March 14, 2003
Maspin expression in invasive breast cancer: association with other prognostic factors
Syed K Mohsin, Ming Zhang, Gary M Clark, et al.
Journal of Mammary Gland Biology and Neoplasia
|
June 13, 2012
Intra-mammary ductal transplantation: a tool to study premalignant progression
Daniel Medina, David G Edwards, Frances Kittrell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2023
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
Jennet M Harvey, Gary M Clark, C Kent Osborne, et al.
Page
of 10